Biosearch Technologies Inc

Riptide Bioscience Inc. is a biotechnology company based in Vallejo, California, focused on developing innovative medicines with significant lifesaving potential. Utilizing small proteins known as Host Defense Peptides (HDPs), the company creates engineered peptides that are designed to enhance efficacy against infections and manage inflammation in various diseases. Over the past seven years, Riptide has produced compelling evidence for its engineered peptide therapeutics through collaborations with academic researchers and funded projects from entities such as the Department of Defense and the National Cancer Institute. The company actively seeks partnerships with pharmaceutical firms to further explore the potential of its proprietary drug candidates. Generated from the website

Cairn Biosciences is a San Francisco-based biotech company that specializes in discovering new medicines by mapping multiscale cell dynamics. Their proprietary COMPASS discovery platform utilizes innovative simulations of living biology to navigate complex disease biology and unlock exclusive routes to novel targets and drugs, with a focus on overcoming acquired resistance to targeted cancer therapies. With a diverse and multidisciplinary team of experts in drug discovery, disease biology, engineering, and computation, Cairn Biosciences is pioneering a new drug discovery paradigm. Their team, led by established biopharma leader and serial drug discovery innovator Mary Ludlam, is dedicated to delivering better therapeutics through their expertise in synthetic cell biology, high-throughput microscopy, computational analysis, and more.Generated from the website

Cureline is a global contract research organization (CRO) specializing in human biospecimen services, including biobanking and laboratory analysis, to support accelerated drug research and development since its inception in 2003. With a robust global clinical network and regulatory expertise, Cureline offers a diverse array of high-quality biospecimens and custom protocols tailored for various therapeutic areas, including oncology, infectious diseases, and neurological disorders. The company operates an extensive HBS biorepository located in the San Francisco Bay area, providing validated human biospecimens for biomarker development and translational research. Cureline has collaborated with over 150 clinical sites worldwide and has successfully completed projects for approximately 700 clients while actively participating in significant NIH scientific consortiums. Generated from the website